Diabetes screening in South Korea: a new estimate of the number needed to screen to detect diabetes (original) (raw)

1. Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022;183:109119.

2. Korean Statistical Information Service. Trend of diabetes prevalence [Internet] Daejeon (KR): Statistics Korea, 2022. [cited 2022 Oct 24]. Available from: https://kosis.kr.

3. National Health Information for Korea Disease Control and Prevention Agency. National chronic disease statistics [Internet] Cheongju (KR): Korea Disease Control and Prevention Agency, 2022. [cited 2022 Oct 24]. Available from: https://health.kdca.go.kr.

4. Jung CH, Son JW, Kang S, et al. Diabetes fact sheets in Korea, 2020: an appraisal of current status. Diabetes Metab J 2021;45:1–10.

5. Stitt AW, Jenkins AJ, Cooper ME. Advanced glycation end products and diabetic complications. Expert Opin Investig Drugs 2002;11:1205–1223.

6. Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N. Impact of diabetes on cardiovascular disease risk and allcause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med 2011;171:404–410.

7. Zoungas S, Woodward M, Li Q, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia 2014;57:2465–2474.

8. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 1988;260:2864–2871.

9. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care 1992;15:815–819.

10. Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 2002;25:1129–1134.

11. Hur KY, Moon MK, Park JS, et al. 2021 Clinical practice guidelines for diabetes mellitus of the Korean Diabetes Association. Diabetes Metab J 2021;45:461–481.

12. Korean Diabetes Association. 2007 Treatment Guideline for Diabetes. Seoul (KR): Korean Diabetes Association, 2007.

13. Choi HH, Choi G, Yoon H, Ha KH, Kim DJ. Rising incidence of diabetes in young adults in South Korea: a national cohort study. Diabetes Metab J 2022;46:803–807.

14. Kweon S, Kim Y, Jang MJ, et al. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol 2014;43:69–77.

15. Lee J, Lee JS, Park SH, Shin SA, Kim K. Cohort profile: the National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol 2017;46:e15.

16. Korean Diabetes Association. 2021 Clinical Practice Guidelines for Diabetes. Seoul (KR): Korean Diabetes Association, 2021.

17. Kim BY, Kang SM, Kang JH, et al. 2020 Korean Society for the Study of Obesity guidelines for the management of obesity in Korea. J Obes Metab Syndr 2021;30:81–92.

18. Cho SM, Lee H, Lee HH, et al. Dyslipidemia fact sheets in Korea 2020: an analysis of nationwide population-based data. J Lipid Atheroscler 2021;10:202–209.

19. Rembold CM. Number needed to screen: development of a statistic for disease screening. BMJ 1998;317:307–312.

20. Chung S, Azar KM, Baek M, Lauderdale DS, Palaniappan LP. Reconsidering the age thresholds for type II diabetes screening in the U.S. Am J Prev Med 2014;47:375–381.

21. US Preventive Services Task Force; Davidson KW, et al.; Barry MJ. Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement. JAMA 2021;326:736–743.

22. American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care 2022;45(Suppl 1):S17–S38.

23. Leiter LA, Barr A, Belanger A, et al. Diabetes Screening in Canada (DIASCAN) Study: prevalence of undiagnosed diabetes and glucose intolerance in family physician offices. Diabetes Care 2001;24:1038–1043.

24. Diabetes Canada Clinical Practice Guidelines Expert Committee; Ekoe JM, Goldenberg R, Katz P. Screening for diabetes in adults. Can J Diabetes 2018;42:Suppl 1. S16–S19.

25. Ha KH, Park CY, Jeong IK, et al. Clinical characteristics of people with newly diagnosed type 2 diabetes between 2015 and 2016: difference by age and body mass index. Diabetes Metab J 2018;42:137–146.

26. Bae JH, Han KD, Ko SH, et al. Diabetes fact sheet in Korea 2021. Diabetes Metab J 2022;46:417–426.

27. Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol 2018;6:69–80.

28. Jonas D, Crotty K, Yun JDY, et al. Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: An Evidence Review for the U. S. Preventive Services Task Force. Evidence Synthesis No 207. Rockville (MD): Agency for Healthcare Research and Quality, 2021.

29. Hamman RF, Wing RR, Edelstein SL, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006;29:2102–2107.

30. Li G, Zhang P, Wang J, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol 2014;2:474–480.

31. Gong Q, Zhang P, Wang J, et al. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. Lancet Diabetes Endocrinol 2019;7:452–461.

32. Rooney MR, Rawlings AM, Pankow JS, et al. Risk of progression to diabetes among older adults with prediabetes. JAMA Intern Med 2021;181:511–519.

33. Choi G, Yoon H, Choi HH, Ha KH, Kim DJ. Association of prediabetes with death and diabetic complications in older adults: the pros and cons of active screening for prediabetes. Age Ageing 2022;51:afac116.

34. Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care 2011;34(Suppl 2):S184–S190.

35. Jeon JY, Ko SH, Kwon HS, et al. Prevalence of diabetes and prediabetes according to fasting plasma glucose and HbA1c. Diabetes Metab J 2013;37:349–357.